Metastatic or recurrent breast cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Participation in ABROAD study (UMIN 000015516) 2) Institutional review board (IRB) approval for research and transportation of blood samples 3) Written informed consent to participate in this study
Exclusion criteria
Exclusion criteria: 1) Patients not adequate for participation in this study at doctors' discretion. 2) Patients not obtained informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Association between grade 2 and more peripheral neuropathy by Abraxane and SNPs | — |
Countries
Japan
Contacts
CSPOR-BC Secretariat